Works matching IS 02724391 AND DT 2000 AND VI 49 AND IP 3

Results: 12

Studies of human osteoblasts in vitro: Estrogen actions and interactions with other hormones at different stages of differentiation.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 174, doi. 10.1002/(SICI)1098-2299(200003)49:3<174::AID-DDR8>3.0.CO;2-S

By:

Rao, Leticia G.;
Murray, Timothy M.

Publication type:

Article

Canadian multicentre osteoporosis study (CaM os).

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 201, doi. 10.1002/(SICI)1098-2299(200003)49:3<201::AID-DDR10>3.0.CO;2-O

By:

Tenenhouse, Alan;
Kreiger, Nancy;
Hanley, David

Publication type:

Article

Cost-effectiveness research in osteoporosis.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 135, doi. 10.1002/(SICI)1098-2299(200003)49:3<135::AID-DDR3>3.0.CO;2-7

By:

Coyle, D.;
Cranney, A.;
Lee, K.M.;
Welch, V.;
Tugwell, P.

Publication type:

Article

Exploring the normal regulation of fetal-placental calcium metabolism through the use of targeted gene ablation in fetal mice.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 167, doi. 10.1002/(SICI)1098-2299(200003)49:3<167::AID-DDR7>3.0.CO;2-N

By:

Kovacs, Christopher S.

Publication type:

Article

Glucocorticoid-induced osteoporosis.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 120, doi. 10.1002/(SICI)1098-2299(200003)49:3<120::AID-DDR2>3.0.CO;2-Q

By:

Adachi, Jonathan D.;
Ioannidis, George

Publication type:

Article

Metabolic bone disease: Lessons from knockout mice.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 159, doi. 10.1002/(SICI)1098-2299(200003)49:3<159::AID-DDR6>3.0.CO;2-L

By:

Karaplis, Andrew C.

Publication type:

Article

Osteoporosis research in Canada.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 119, doi. 10.1002/(SICI)1098-2299(200003)49:3<119::AID-DDR1>3.0.CO;2-3

By:

Triggle, Chris;
Hanley, David

Publication type:

Article

Genetic determinants of bone mass acquisition and risk for osteoporosis.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 216, doi. 10.1002/(SICI)1098-2299(200003)49:3<216::AID-DDR12>3.0.CO;2-A

By:

Rubin, Laurence A.;
Patel, Millan S.;
Cole, David E. C.

Publication type:

Article

Bone quality in animal models of osteoporosis.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 146, doi. 10.1002/(SICI)1098-2299(200003)49:3<146::AID-DDR5>3.0.CO;2-Y

By:

Grynpas, Marc D.;
Chachra, Debbie;
Lundon, Kathleen

Publication type:

Article

P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 187, doi. 10.1002/(SICI)1098-2299(200003)49:3<187::AID-DDR9>3.0.CO;2-F

By:

Dixon, S. Jeffrey;
Sims, Stephen M.

Publication type:

Article

Osteoprogenitor cell differentiation to mature bone-forming osteoblasts.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 206, doi. 10.1002/(SICI)1098-2299(200003)49:3<206::AID-DDR11>3.0.CO;2-G

By:

Aubin, Jane E.;
Heersche, Johan N.M.

Publication type:

Article

Medical treatment of osteogenesis imperfecta.

Published in:

Drug Development Research, 2000, v. 49, n. 3, p. 141, doi. 10.1002/(SICI)1098-2299(200003)49:3<141::AID-DDR4>3.0.CO;2-F

By:

Plotkin, Horacio;
Glorieux, Francis H.

Publication type:

Article